Sitomet Tablet 50 mg + 1000 mg combines Sitagliptin (50 mg) and Metformin Hydrochloride (1000 mg) to provide dual-action management of type 2 diabetes mellitus. Sitagliptin, a DPP-4 inhibitor, enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner, while Metformin improves insulin sensitivity and reduces hepatic glucose production.

This combination therapy is indicated for patients who are not adequately controlled with diet, exercise, or monotherapy. Sitomet helps achieve better glycemic control, reducing both fasting and postprandial blood sugar levels, while minimizing the risk of hypoglycemia.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Sitagliptin 50 mg
• Metformin Hydrochloride 1000 mg

Mechanism of Action

Sitagliptin:

• Inhibits the enzyme DPP-4, increasing levels of incretin hormones (GLP-1 and GIP).
• Enhances insulin release after meals and reduces glucagon secretion, lowering blood glucose.

Metformin:

• Reduces hepatic glucose production (gluconeogenesis)
• Improves peripheral insulin sensitivity, promoting glucose uptake by muscles
• Delays intestinal absorption of glucose

Together, Sitomet provides complementary mechanisms to optimize glycemic control in type 2 diabetes patients.

Indications

Sitomet Tablet is indicated for:

• Adults with type 2 diabetes mellitus inadequately controlled with diet and exercise
• Patients requiring dual therapy for better fasting and postprandial glucose management
• Combination therapy with diet and lifestyle modification to reduce diabetes-related complications

Dosage & Administration

• Recommended dose: 1 tablet twice daily with meals, or as prescribed by the physician
• Take with food to reduce gastrointestinal side effects caused by Metformin
• Dose may need adjustment in patients with renal or hepatic impairment
• Regular monitoring of blood glucose, HbA1c, and renal function is advised
• Maintain diet and exercise regimen as prescribed

Benefits

• Dual-action therapy addresses both insulin secretion and insulin resistance
• Effective control of fasting and postprandial blood sugar
• Reduces risk of diabetes-related complications
• Convenient fixed-dose combination improves patient compliance
• Minimizes risk of hypoglycemia compared to sulfonylurea-based regimens

Possible Side Effects

Common side effects:

• Gastrointestinal disturbances (nausea, diarrhea, abdominal discomfort)
• Headache
• Mild dizziness

Rare but serious effects:

• Lactic acidosis (rare, associated with Metformin in renal impairment)
• Allergic reactions (rash, swelling, itching)
• Hypoglycemia (rare when used alone, more likely with other antidiabetic drugs)

Precautions & Warnings

• Contraindicated in patients with severe renal or hepatic impairment
• Avoid use during acute illness, dehydration, or alcohol abuse
• Not recommended for type 1 diabetes or diabetic ketoacidosis
• Monitor kidney function regularly due to Metformin content
• Discontinue if signs of lactic acidosis (muscle pain, fatigue, rapid breathing) occur
• Inform your doctor about all other medications being taken

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store at 20–25°C in a dry, cool place
• Keep the tablet in its original packaging until use
• Protect from moisture, heat, and sunlight
• Keep out of reach of children

Conclusion

Sitomet Tablet 50 mg + 1000 mg (Sitagliptin + Metformin Hydrochloride) offers effective dual-action therapy for type 2 diabetes mellitus. By combining enhanced insulin secretion with improved insulin sensitivity, it ensures better glycemic control, reduces complications, and provides convenient, once- or twice-daily dosing for long-term diabetes management.